Works matching AU Bando, Hiroko

Results: 60
    1

    Real-world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first- or second-line treatment for hormone receptor–positive, HER2-negative advanced or metastatic breast cancer

    Published in:
    Breast Cancer (13406868), 2025, v. 32, n. 4, p. 841, doi. 10.1007/s12282-025-01713-7
    By:
    • Yoshinami, Tetsuhiro;
    • Takano, Yuko;
    • Ozaki, Yukinori;
    • Kajiwara, Yukiko;
    • Yamamoto, Mitsugu;
    • Watanabe, Ken-ichi;
    • Tsukabe, Masami;
    • Fujisawa, Fumie;
    • Nagai, Shigenori E.;
    • Shibata, Nobuhiro;
    • Oshiro, Chiya;
    • Bando, Hiroko;
    • Tsunoda, Nobuyuki;
    • Yamagami, Kazuhiko;
    • Koizumi, Kei;
    • Takada, Masahiro;
    • Toriguchi, Naoko;
    • Sekine, Nobuyuki;
    • Kawaguchi, Tsutomu;
    • Saji, Shigehira
    Publication type:
    Article
    2
    3
    4
    5

    Cystoid macular edema induced by nab-paclitaxel.

    Published in:
    Breast Cancer (13406868), 2015, v. 22, n. 3, p. 324, doi. 10.1007/s12282-012-0373-y
    By:
    • Tanaka, Yuko;
    • Bando, Hiroko;
    • Hara, Hisato;
    • Ito, Yasuaki;
    • Okamoto, Yoshifumi
    Publication type:
    Article
    6
    7
    8
    9
    10

    Current status of antibody therapy for breast cancer.

    Published in:
    Breast Cancer (13406868), 2004, v. 11, n. 1, p. 10, doi. 10.1007/BF02967994
    By:
    • Toi, Masakazu;
    • Takada, Masahiro;
    • Bando, Hiroko;
    • Toyama, Kazumi;
    • Yamashiro, Hiroyasu;
    • Horiguchi, Shinichiro;
    • Saji, Shigehira
    Publication type:
    Article
    11
    12

    Aromatase and aromatase inhibitors.

    Published in:
    Breast Cancer (13406868), 2001, v. 8, n. 4, p. 329, doi. 10.1007/BF02967533
    By:
    • Toi, Masakazu;
    • Bando, Hiroko;
    • Saji, Shigehira
    Publication type:
    Article
    13
    14
    15
    16
    17
    18

    Genomic and transcriptomic profiling of pre‐ and postneoadjuvant chemotherapy triple negative breast cancer tumors.

    Published in:
    Cancer Science, 2024, v. 115, n. 12, p. 3928, doi. 10.1111/cas.16339
    By:
    • Nishimura, Tomomi;
    • Velaga, Ravi;
    • Masuda, Norikazu;
    • Kawaguchi, Kosuke;
    • Kawaguchi, Shuji;
    • Takada, Masahiro;
    • Maeshima, Yurina;
    • Tanaka, Sunao;
    • Kikawa, Yuichiro;
    • Kadoya, Takayuki;
    • Bando, Hiroko;
    • Nakamura, Rikiya;
    • Yamamoto, Yutaka;
    • Ueno, Takayuki;
    • Yasojima, Hiroyuki;
    • Ishiguro, Hiroshi;
    • Morita, Satoshi;
    • Ohno, Shinji;
    • Haga, Hironori;
    • Matsuda, Fumihiko
    Publication type:
    Article
    19
    20
    21
    22
    23

    Trastuzumab: updates and future issues.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2005, v. 56, p. 94, doi. 10.1007/s00280-005-0110-8
    By:
    • Toi, Masakazu;
    • Horiguchi, Kazumi;
    • Bando, Hiroko;
    • Saji, Shigehira;
    • Chow, Louis W. C.
    Publication type:
    Article
    24

    Long-Term Outcomes of a Randomized Study of Neoadjuvant Induction Dual HER2 Blockade with Trastuzumab and Lapatinib Followed by Weekly Paclitaxel Plus Dual HER2 Blockade for HER2-Positive Primary Breast Cancer (Neo-Lath Study).

    Published in:
    Cancers, 2021, v. 13, n. 16, p. 4008, doi. 10.3390/cancers13164008
    By:
    • Tokunaga, Eriko;
    • Masuda, Norikazu;
    • Yamamoto, Naohito;
    • Iwata, Hiroji;
    • Bando, Hiroko;
    • Aruga, Tomoyuki;
    • Ohtani, Shoichiro;
    • Fujisawa, Tomomi;
    • Takano, Toshimi;
    • Inoue, Kenichi;
    • Suganuma, Nobuyasu;
    • Takada, Masahiro;
    • Aogi, Kenjiro;
    • Sakurai, Kenichi;
    • Shigematsu, Hideo;
    • Kuroi, Katsumasa;
    • Haga, Hironori;
    • Ohno, Shinji;
    • Morita, Satoshi;
    • Toi, Masakazu
    Publication type:
    Article
    25

    Correction to: Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2.

    Published in:
    2022
    By:
    • Tozawa, Akiko;
    • Kimura, Fuminori;
    • Takai, Yasushi;
    • Nakajima, Takeshi;
    • Ushijima, Kimio;
    • Kobayashi, Hiroaki;
    • Satoh, Toyomi;
    • Harada, Miyuki;
    • Sugimoto, Kohei;
    • Saji, Shigehira;
    • Shimizu, Chikako;
    • Akiyama, Kyoko;
    • Bando, Hiroko;
    • Kuwahara, Akira;
    • Furui, Tatsuro;
    • Okada, Hiroshi;
    • Kawai, Koji;
    • Shinohara, Nobuo;
    • Nagao, Koichi;
    • Kitajima, Michio
    Publication type:
    Correction Notice
    26

    Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1.

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 2, p. 265, doi. 10.1007/s10147-021-02081-w
    By:
    • Harada, Miyuki;
    • Kimura, Fuminori;
    • Takai, Yasushi;
    • Nakajima, Takeshi;
    • Ushijima, Kimio;
    • Kobayashi, Hiroaki;
    • Satoh, Toyomi;
    • Tozawa, Akiko;
    • Sugimoto, Kohei;
    • Saji, Shigehira;
    • Shimizu, Chikako;
    • Akiyama, Kyoko;
    • Bando, Hiroko;
    • Kuwahara, Akira;
    • Furui, Tatsuro;
    • Okada, Hiroshi;
    • Kawai, Koji;
    • Shinohara, Nobuo;
    • Nagao, Koichi;
    • Kitajima, Michio
    Publication type:
    Article
    27

    Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2.

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 2, p. 281, doi. 10.1007/s10147-021-02076-7
    By:
    • Tozawa, Akiko;
    • Kimura, Fuminori;
    • Takai, Yasushi;
    • Nakajima, Takeshi;
    • Ushijima, Kimio;
    • Kobayashi, Hiroaki;
    • Satoh, Toyomi;
    • Harada, Miyuki;
    • Sugimoto, Kohei;
    • Saji, Shigehira;
    • Shimizu, Chikako;
    • Akiyama, Kyoko;
    • Bando, Hiroko;
    • Kuwahara, Akira;
    • Furui, Tatsuro;
    • Okada, Hiroshi;
    • Kawai, Koji;
    • Shinohara, Nobuo;
    • Nagao, Koichi;
    • Kitajima, Michio
    Publication type:
    Article
    28
    29

    Overnight fasting before lapatinib administration to breast cancer patients leads to reduced toxicity compared with nighttime dosing: a retrospective cohort study from a randomized clinical trial.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 24, p. 9246, doi. 10.1002/cam4.3528
    By:
    • Tsuda, Moe;
    • Ishiguro, Hiroshi;
    • Toriguchi, Naoko;
    • Masuda, Norikazu;
    • Bando, Hiroko;
    • Ohgami, Masahiro;
    • Homma, Masato;
    • Morita, Satoshi;
    • Yamamoto, Naohito;
    • Kuroi, Katsumasa;
    • Yanagita, Yasuhiro;
    • Takano, Toshimi;
    • Shimizu, Satoru;
    • Toi, Masakazu
    Publication type:
    Article
    30

    Dental Caries in Children Under Five Years of Age in Mongolia.

    Published in:
    International Journal of Environmental Research & Public Health, 2020, v. 17, n. 13, p. 4741, doi. 10.3390/ijerph17134741
    By:
    • Nishino, Mizuho;
    • Amarsaikhan, Bazar;
    • Furumoto, Nanayo;
    • Hirao, Saki;
    • Bando, Hiroko;
    • Nakagawa, Akemi;
    • Nomingerel, Sukhbaatar;
    • Bolorchimeg, Begzsuren;
    • Fujimoto, Masami
    Publication type:
    Article
    31

    A randomized, 3-arm, neoadjuvant, phase 2 study comparing docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T-DM1+P), and T-DM1+P in HER2-positive primary breast cancer

    Published in:
    Breast Cancer Research & Treatment, 2020, v. 180, n. 1, p. 135, doi. 10.1007/s10549-020-05524-6
    By:
    • Masuda, Norikazu;
    • Ohtani, Shoichiro;
    • Takano, Toshimi;
    • Inoue, Kenichi;
    • Suzuki, Eiji;
    • Nakamura, Rikiya;
    • Bando, Hiroko;
    • Ito, Yoshinori;
    • Ishida, Kazushige;
    • Yamanaka, Takashi;
    • Kuroi, Katsumasa;
    • Yasojima, Hiroyuki;
    • Kasai, Hiroi;
    • Takasuka, Tsuyoshi;
    • Sakurai, Takaki;
    • Kataoka, Tatsuki R.;
    • Morita, Satoshi;
    • Ohno, Shinji;
    • Toi, Masakazu
    Publication type:
    Article
    32

    The utility of DHL-HisZnNa, a novel antioxidant, against anticancer agent-induced alopecia in breast cancer patients: a multicenter phase II clinical trial.

    Published in:
    Breast Cancer Research & Treatment, 2019, v. 176, n. 3, p. 625, doi. 10.1007/s10549-019-05164-5
    By:
    • Sagawa, Noriko;
    • Ohno, Shinji;
    • Hiratsuka, Takahiro;
    • Kondo, Naoto;
    • Iwata, Hiroji;
    • Bando, Hiroko;
    • Ohyama, Tetsuji;
    • Ishida, Mayumi;
    • Kono, Yohei;
    • Nakajima, Kentaro;
    • Empuku, Shinichiro;
    • Nishikawa, Setsuko;
    • Irie, Yoshiko;
    • Inomata, Masafumi;
    • Kitano, Seigo
    Publication type:
    Article
    33
    34

    Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 Study.

    Published in:
    Journal of Cancer, 2023, v. 14, n. 14, p. 2644, doi. 10.7150/jca.87169
    By:
    • Hirotoshi Iihara;
    • Mototsugu Shimokawa;
    • Hiroko Bando;
    • Yoshimi Niwa;
    • Yutaka Mizuno;
    • Yoshihiro Kawaguchi;
    • Mika Kitahora;
    • Akari Murakami;
    • Masaaki Kawai;
    • Kazushige Ishida;
    • Makoto Takeuchi;
    • Kazuhiro Ishihara;
    • Tomokazu Iyoda;
    • Takumi Nakada;
    • Atsuko Ogiso;
    • Yasuyuki Kojima;
    • Fumiyoshi Kumagai;
    • Aya Sawa;
    • Ryutaro Mori;
    • Kosuke Higuchi
    Publication type:
    Article
    35

    Evaluation of Trastuzumab Without Chemotherapy as a Post-operative Adjuvant Therapy in HER2-positive Elderly Breast Cancer Patients: Randomized Controlled Trial [RESPECT (N-SAS BC07)]†.

    Published in:
    Japanese Journal of Clinical Oncology, 2011, v. 41, n. 5, p. 709, doi. 10.1093/jjco/hyr011
    By:
    • Sawaki, Masataka;
    • Tokudome, Nahomi;
    • Mizuno, Toshiro;
    • Nakayama, Takahiro;
    • Taira, Naruto;
    • Bando, Hiroko;
    • Murakami, Shigeru;
    • Yamamoto, Yutaka;
    • Kashiwaba, Masahiro;
    • Iwata, Hiroji;
    • Uemura, Yukari;
    • Ohashi, Yasuo
    Publication type:
    Article
    36
    37
    38
    39

    Increased Soluble CD155 in the Serum of Cancer Patients.

    Published in:
    PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0152982
    By:
    • Iguchi-Manaka, Akiko;
    • Okumura, Genki;
    • Kojima, Hiroshi;
    • Cho, Yukiko;
    • Hirochika, Rei;
    • Bando, Hiroko;
    • Sato, Toyomi;
    • Yoshikawa, Hiroyuki;
    • Hara, Hisato;
    • Shibuya, Akira;
    • Shibuya, Kazuko
    Publication type:
    Article
    40
    41
    42
    43

    Time-series blood cytokine profiles correlate with treatment responses in triple-negative breast cancer patients.

    Published in:
    British Journal of Cancer, 2024, v. 130, n. 6, p. 1023, doi. 10.1038/s41416-023-02527-0
    By:
    • Saldajeno, Don Pietro;
    • Kawaoka, Shinpei;
    • Masuda, Norikazu;
    • Tanaka, Sunao;
    • Bando, Hiroko;
    • Nishimura, Tomomi;
    • Kadoya, Takayuki;
    • Yamanaka, Takashi;
    • Imoto, Shigeru;
    • Velaga, Ravindranath M.;
    • Tamura, Nobuko;
    • Aruga, Tomoyuki;
    • Ikeda, Kazushi;
    • Fukui, Yukiko;
    • Maeshima, Yurina;
    • Takada, Masahiro;
    • Suzuki, Eiji;
    • Ueno, Takayuki;
    • Ogawa, Seishi;
    • Haga, Hironori
    Publication type:
    Article
    44
    45
    46
    47
    48

    Efficacy of the eribulin, pertuzumab, and trastuzumab combination therapy for human epidermal growth factor receptor 2–positive advanced or metastatic breast cancer: a multicenter, single arm, phase II study (JBCRG-M03 study).

    Published in:
    Investigational New Drugs, 2021, v. 39, n. 1, p. 217, doi. 10.1007/s10637-020-00991-6
    By:
    • Yamashita, Toshinari;
    • Kawaguchi, Hidetoshi;
    • Masuda, Norikazu;
    • Kitada, Masahiro;
    • Narui, Kazutaka;
    • Hattori, Masaya;
    • Yoshinami, Tetsuhiro;
    • Matsunami, Nobuki;
    • Yanagihara, Kazuhiro;
    • Kawasoe, Teru;
    • Nagashima, Takeshi;
    • Bando, Hiroko;
    • Yano, Hiroshi;
    • Hasegawa, Yoshie;
    • Nakamura, Rikiya;
    • Kashiwaba, Masahiro;
    • Morita, Satoshi;
    • Ohno, Shinji;
    • Toi, Masakazu
    Publication type:
    Article
    49

    Evaluation of the Clinical Utility of the ICG Fluorescence Method Compared with the Radioisotope Method for Sentinel Lymph Node Biopsy in Breast Cancer.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2016, v. 23, n. 1, p. 44, doi. 10.1245/s10434-015-4809-4
    By:
    • Sugie, Tomoharu;
    • Kinoshita, Takayuki;
    • Masuda, Norikazu;
    • Sawada, Terumasa;
    • Yamauchi, Akira;
    • Kuroi, Katsumasa;
    • Taguchi, Tetsuya;
    • Bando, Hiroko;
    • Yamashiro, Hiroyasu;
    • Lee, Tecchuu;
    • Shinkura, Nobuhiko;
    • Kato, Hironori;
    • Ikeda, Takafumi;
    • Yoshimura, Kenichi;
    • Ueyama, Hanae;
    • Toi, Masakazu
    Publication type:
    Article
    50

    Characteristics, treatment trends, and long-term outcomes of Japanese patients with pregnancy-associated breast cancer (PABC).

    Published in:
    Breast Cancer (13406868), 2022, v. 29, n. 5, p. 825, doi. 10.1007/s12282-022-01362-0
    By:
    • Kataoka, Akemi;
    • Ueno, Takayuki;
    • Yamauchi, Hideko;
    • Uehiro, Natsue;
    • Takahata, Chikako;
    • Takahashi, Yoko;
    • Nakashima, Eri;
    • Ogiya, Akiko;
    • Sakai, Takehiko;
    • Kitagawa, Dai;
    • Morizono, Hidetomo;
    • Miyagi, Yumi;
    • Iwase, Takuji;
    • Kitano, Atsuko;
    • Fukatsu, Yumi;
    • Tamura, Nobuko;
    • Kawano, Junko;
    • Bando, Hiroko;
    • Tamaki, Kentaro;
    • Shiota, Kyoko
    Publication type:
    Article